LifeBridge Health Implements AI Tool for Enhanced Sepsis Detection
LifeBridge Health's Sinai Hospital in Baltimore has introduced an AI-powered diagnostic tool, Sepsis ImmunoScore, developed by Prenosis, to improve the detection of sepsis. This tool, which received FDA authorization in 2024, analyzes 22 parameters to identify early signs of sepsis, potentially reducing the time to diagnosis to within 24 hours. The tool's implementation follows a collaborative research effort involving multiple centers, including Sinai Hospital, which contributed to the dataset used to train the AI. Sepsis, a challenging and costly condition to manage, affects millions annually in the U.S., with significant mortality rates. The AI tool aims to address diagnostic uncertainties and improve patient outcomes by integrating with hospital electronic medical records.